Biomarker testing is crucial for personalized oncology care, aiding in risk stratification and treatment decisions, but faces challenges in uptake and education. Multistakeholder partnerships and ...
Oncology pharmacists bridge gaps in test ordering, result interpretation, and therapy access, ensuring timely and effective ...
A panelist discusses how folate receptor alpha (FRα) expression testing plays a crucial role in determining eligibility for mirvetuximab soravtansine (an antibody-drug conjugate therapy), emphasizing ...
Changing the landscape of health care through biomarker testing that could revolutionize how doctors diagnose and treat various medical conditions. We go on to the record taking a look at what this ...
Given the opportunity, 90% of Americans say they would take a blood biomarker test for Alzheimer’s disease (AD) — even in the absence of symptoms. Notably, 80% say they wouldn’t wait for a physician ...
Source: Getty Images Despite proven benefits, biomarker tests remain underused in clinical practice. By examining genetic markers from urine or tissue samples, biomarkers provide a more precise ...
Hosted on MSN
Just How Many Biomarkers Do You Really Need to Test?
HEAVYWEIGHT WELLNESS COMPANIES in the $77.6 billion global biomarker market are promising to enhance your healthspan through huge batches of screenings. Some services, like InsideTracker, test ...
Biomarker testing has become “increasingly critical” in the care of non-small cell lung cancer.A new investigation into testing rates proved “reassuring” to Kenneth L. Kehl, MD, MPH, assistant ...
Only 35% of advanced cancer patients received comprehensive genomic profiling testing. Tested patients were more likely to receive targeted therapies. Testing rates increased slightly over time and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback